Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 SEK | -0.95% | -0.95% | +108.00% |
27/05 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
27/05 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
Sales 2024 * | 65.65M 6.24M 520M | Sales 2025 * | 138M 13.12M 1.09B | Capitalization | 809M 76.88M 6.41B |
---|---|---|---|---|---|
Net income 2024 * | -111M -10.55M -880M | Net income 2025 * | -28M -2.66M -222M | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | 11.93M 1.13M 94.51M | Net Debt 2025 * | 259M 24.6M 2.05B | EV / Sales 2025 * | 7.73 x |
P/E ratio 2024 * |
-5.06
x | P/E ratio 2025 * |
-4.31
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.48% |
Latest transcript on IRLAB Therapeutics AB
1 day | -0.95% | ||
1 week | -0.95% | ||
1 month | +36.84% | ||
3 months | +6.48% | ||
6 months | +130.77% | ||
Current year | +108.00% |
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 01/13/01 |
Chief Executive Officer | 71 | 06/17/06 | |
Nicholas Waters
FOU | Founder | 62 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 01/16/01 |
Rein Piir
BRD | Director/Board Member | 66 | 01/16/01 |
Chairman | 66 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 15.6 | -0.95% | 95,361 |
30/24/30 | 15.75 | -.--% | 19,888 |
29/24/29 | 15.75 | -2.78% | 23,182 |
28/24/28 | 16.2 | +4.52% | 63,901 |
27/24/27 | 15.5 | -1.59% | 44,308 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 08:59 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.00% | 76.81M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- IRLAB A Stock